BG63893B1 - Нови модификации на 2-амино-4-(4-флуоробензиламино)- 1-етоксикарбониламинобензен и методи за тяхното получаване - Google Patents

Нови модификации на 2-амино-4-(4-флуоробензиламино)- 1-етоксикарбониламинобензен и методи за тяхното получаване Download PDF

Info

Publication number
BG63893B1
BG63893B1 BG103657A BG10365799A BG63893B1 BG 63893 B1 BG63893 B1 BG 63893B1 BG 103657 A BG103657 A BG 103657A BG 10365799 A BG10365799 A BG 10365799A BG 63893 B1 BG63893 B1 BG 63893B1
Authority
BG
Bulgaria
Prior art keywords
modification
compound
preparation
solvent
modifications
Prior art date
Application number
BG103657A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG103657A (en
Inventor
Peter Meisel
Karl-Friedrich Landgraf
Juergen Schaefer
Wilfried Thiel
Matthias Rischer
Alfred Olbrich
Bernhard Kutscher
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of BG103657A publication Critical patent/BG103657A/xx
Publication of BG63893B1 publication Critical patent/BG63893B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
BG103657A 1997-01-20 1999-08-10 Нови модификации на 2-амино-4-(4-флуоробензиламино)- 1-етоксикарбониламинобензен и методи за тяхното получаване BG63893B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19701694A DE19701694A1 (de) 1997-01-20 1997-01-20 Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung
PCT/EP1998/000086 WO1998031663A1 (de) 1997-01-20 1998-01-09 Neue modifikationen des 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonyl-aminobenzen sowie verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
BG103657A BG103657A (en) 2000-02-29
BG63893B1 true BG63893B1 (bg) 2003-05-30

Family

ID=7817756

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103657A BG63893B1 (bg) 1997-01-20 1999-08-10 Нови модификации на 2-амино-4-(4-флуоробензиламино)- 1-етоксикарбониламинобензен и методи за тяхното получаване

Country Status (31)

Country Link
US (2) US5914425A (ru)
EP (1) EP0956281B1 (ru)
JP (1) JP4138886B2 (ru)
CN (1) CN1125812C (ru)
AR (1) AR015349A1 (ru)
AT (1) ATE222235T1 (ru)
AU (1) AU730776B2 (ru)
BG (1) BG63893B1 (ru)
BR (1) BR9806784A (ru)
CA (3) CA2278201C (ru)
CZ (1) CZ301778B6 (ru)
DE (2) DE19701694A1 (ru)
DK (1) DK0956281T3 (ru)
EG (1) EG21239A (ru)
ES (1) ES2178152T3 (ru)
HK (1) HK1024230A1 (ru)
HU (1) HU227625B1 (ru)
ID (1) ID22645A (ru)
IL (1) IL130384A (ru)
IS (1) IS2115B (ru)
NO (2) NO311642B1 (ru)
NZ (1) NZ336205A (ru)
PL (1) PL195956B1 (ru)
PT (1) PT956281E (ru)
RU (1) RU2186765C2 (ru)
SK (1) SK285303B6 (ru)
TR (1) TR199901674T2 (ru)
TW (1) TW531527B (ru)
UA (1) UA63937C2 (ru)
WO (1) WO1998031663A1 (ru)
ZA (1) ZA98319B (ru)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI287984B (en) 2000-10-17 2007-10-11 Wyeth Corp Pharmaceutical composition for modulating bladder function
US6589986B2 (en) 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders
AR033095A1 (es) * 2001-04-04 2003-12-03 Wyeth Corp Metodos para el tratamiento de motilidad gastrica hiperactiva
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US20080045534A1 (en) * 2006-08-18 2008-02-21 Valeant Pharmaceuticals North America Derivatives of 1,3-diamino benzene as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
ES2420960T3 (es) * 2006-08-23 2013-08-28 Valeant Pharmaceuticals International Derivados de 4-(N-azacicloalquil)anilidas como moduladores de los canales de potasio
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
ES2375417T3 (es) * 2006-11-28 2012-02-29 Valeant Pharmaceuticals International Análogos 1,4-diamino bicíclicos de retigabina como moduladores de los canales de potasio.
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
CA2731008A1 (en) * 2008-07-18 2010-01-21 Valeant Pharmaceuticals International Modified release formulation and methods of use
US20100323015A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
DE102009013612A1 (de) 2009-03-17 2010-09-23 Ratiopharm Gmbh Retigabin-Tabletten, bevorzugt mit modifizierter Freisetzung
DE102009013611A1 (de) 2009-03-17 2010-09-23 Ratiopharm Gmbh Festes Retigabin in nicht-kristalliner Form
DE102009013613A1 (de) 2009-03-17 2010-09-23 Ratiopharm Gmbh Trockenverarbeitung von Retigabin
WO2011039369A2 (en) 2009-10-02 2011-04-07 Medichem S.A. Amorphous forms of a 2-amino-4-(4-fluorobenzylamino)phenylcarbamate derivative
EA201290659A1 (ru) 2010-01-20 2013-05-30 Глэксо Груп Лимитед Новая композиция ретигабина
US20130131164A1 (en) * 2010-02-19 2013-05-23 Medichem, S.A. Stabilized phenylcarbamate derivative in solid state
CN202095728U (zh) * 2010-10-29 2012-01-04 假日集团控股有限公司 行李箱把手
CN102464233A (zh) * 2010-11-18 2012-05-23 江苏邦威机械制造有限公司 一种卧式差速缠丝机用应力发生装置
US9102593B2 (en) 2011-01-18 2015-08-11 Glaxo Group Limited Process for the preparation of retigabine
CN102241608A (zh) * 2011-05-12 2011-11-16 天津市汉康医药生物技术有限公司 瑞替加滨化合物及其组合物
WO2013008250A2 (en) * 2011-07-01 2013-01-17 Dr.Reddys Laboratories Limited. Crystalline form of retigabine and processes for mixture of retigabine crystalline modifications
WO2013011518A1 (en) 2011-07-21 2013-01-24 Arch Pharmalabs Limited Process for the preparation of retigabine of the formula i and pharmaceutically acceptable salts thereof
CN102531966B (zh) * 2011-12-23 2013-07-24 山东创新药物研发有限公司 瑞替加滨的晶型d及其制备方法
WO2013114379A1 (en) * 2012-01-30 2013-08-08 Symed Labs Limited Novel polymorphs of n-[2-amino-4-(4-fluorobenzylamino)-phenyl] carbamic acid ethyl ester and processes thereof
CN103373941B (zh) * 2012-04-11 2016-08-17 浙江九洲药物科技有限公司 瑞替加滨及其中间体的制备方法
WO2013179298A2 (en) * 2012-04-23 2013-12-05 Cadila Healthcare Limited A process for preparation of phenyl carbamate derivative and polymorphic forms thereof
WO2014023270A1 (en) 2012-08-09 2014-02-13 Zentiva, K.S. Salts or co-crystals of ethyl n-[2-amino-4-[(4-fluorophenyl)methylamino]-phenyl]carbamate
CN102964273B (zh) * 2012-12-06 2014-04-02 北京英科博雅科技有限公司 瑞替加滨的新晶型f及其制备方法
USD773819S1 (en) 2015-05-27 2016-12-13 Travelpro Products, Inc. Handle for luggage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (de) * 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung

Also Published As

Publication number Publication date
UA63937C2 (ru) 2004-02-16
IS2115B (is) 2006-06-15
DE19701694A1 (de) 1998-07-23
BG103657A (en) 2000-02-29
CA2634811C (en) 2012-11-20
NO311642B1 (no) 2001-12-27
PL335647A1 (en) 2000-05-08
ZA98319B (en) 1998-05-07
SK95699A3 (en) 2000-03-13
IL130384A (en) 2003-02-12
PL195956B1 (pl) 2007-11-30
CA2634811A1 (en) 1998-07-23
CN1125812C (zh) 2003-10-29
WO1998031663A1 (de) 1998-07-23
HUP0000944A3 (en) 2000-10-30
CA2278201C (en) 2009-06-16
NZ336205A (en) 2000-01-28
ATE222235T1 (de) 2002-08-15
BR9806784A (pt) 2000-05-02
AR015349A1 (es) 2001-05-02
AU6208198A (en) 1998-08-07
JP4138886B2 (ja) 2008-08-27
HU227625B1 (en) 2011-09-28
NO2011017I2 (no) 2013-04-02
US6538151B1 (en) 2003-03-25
CZ301778B6 (cs) 2010-06-23
NO2011017I1 (no) 2011-09-26
EP0956281B1 (de) 2002-08-14
US5914425A (en) 1999-06-22
ES2178152T3 (es) 2002-12-16
RU2186765C2 (ru) 2002-08-10
DK0956281T3 (da) 2002-11-04
TR199901674T2 (ru) 1999-10-21
CA2632585A1 (en) 1998-07-23
IS5098A (is) 1999-06-29
EP0956281A1 (de) 1999-11-17
EG21239A (en) 2001-03-31
HK1024230A1 (en) 2000-10-05
SK285303B6 (sk) 2006-10-05
HUP0000944A2 (hu) 2000-09-28
CZ250899A3 (cs) 1999-11-17
ID22645A (id) 1999-12-02
JP2001508077A (ja) 2001-06-19
CA2632585C (en) 2010-08-24
IL130384A0 (en) 2000-06-01
PT956281E (pt) 2002-12-31
TW531527B (en) 2003-05-11
CA2278201A1 (en) 1998-07-23
AU730776B2 (en) 2001-03-15
NO993452L (no) 1999-07-13
NO993452D0 (no) 1999-07-13
DE59805186D1 (de) 2002-09-19
CN1243506A (zh) 2000-02-02

Similar Documents

Publication Publication Date Title
BG63893B1 (bg) Нови модификации на 2-амино-4-(4-флуоробензиламино)- 1-етоксикарбониламинобензен и методи за тяхното получаване
EP2535339A1 (en) Polymorphs of dasatinib, preparation methods and pharmaceutical compositions thereof
RU2467012C2 (ru) Способ очистки стауроспорина и способ получения n-бензоилстауроспорина
CN112142679B (zh) 一种吉非替尼与香草酸共晶甲醇溶剂合物及其制备方法
CZ364696A3 (en) Novel crystalline modification of 1-cyclopropyl-7-(/s,s/-2,8-diazabicyclo/4.3.0/non-8-yl)-6-fluoro- -1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid hydrochloride, process of its preparation and pharmaceutical compositions containing thereof
JP2002519422A (ja) パロキセチンメタンスルホネート
KR19990023433A (ko) 결정 형태의 ｎ-(4-트리플루오로메틸페닐)-5-메틸이소옥사졸-4-카복스아미드
AU1641592A (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
CN109516991B (zh) 一种枸橼酸托法替尼晶型化合物及其制备方法
CN114127085A (zh) 一种肽酰胺盐及其制备方法和在医药上的用途
KR20210040034A (ko) 이사부코나조늄 설페이트의 정제 방법
KR102111247B1 (ko) 다파글리플로진 무정형 형태의 공결정 또는 복합제
KR101849775B1 (ko) N-아로일우레아 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 암 예방 및 치료용 조성물
KR19980064287A (ko) 다형태를 갖는 독사조신 메실레이트의 새로운 형태(제 ii 형)
JP2022508864A (ja) チロシンキナーゼ阻害剤のマレイン酸塩の結晶形及びその調製方法
EP4431515A1 (en) Novel crystal forms of peptide boric acid compound and preparation methods therefor
JP2707012B2 (ja) Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
CN106518773A (zh) 一种雄性激素受体抑制剂的结晶形式及其制备方法
US7449584B2 (en) N-(2((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide Crystalline Form 1
CN114437026A (zh) 一种低组合物杂质的苹果酸奈诺沙星原料药及其制备方法
EP1674101B1 (fr) Dérivés cinnamates de benzo [b]pyrano[3,2-h]acridin-7-one, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CN116462610A (zh) 一种光学活性二胺衍生物盐的结晶形式及其制备方法
JPH05155820A (ja) Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
CN115197223A (zh) 一种甲氨蝶呤晶型a化合物及其制备方法
KR20190005679A (ko) 1-[2-(2,4-디메틸페닐설파닐)페닐]피페라진의 신규염 및 이의 제조방법